Ocumetics Technology Corp (OTC) - Net Assets
Based on the latest financial reports, Ocumetics Technology Corp (OTC) has net assets worth CA$-5.09 Million CAD (≈ $-3.68 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.15 Million ≈ $834.97K USD) and total liabilities (CA$6.24 Million ≈ $4.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ocumetics Technology Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-5.09 Million |
| % of Total Assets | -440.69% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1068.09 |
Ocumetics Technology Corp - Net Assets Trend (2021–2025)
This chart illustrates how Ocumetics Technology Corp's net assets have evolved over time, based on quarterly financial data. See OTC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Ocumetics Technology Corp (2021–2025)
The table below shows the annual net assets of Ocumetics Technology Corp from 2021 to 2025. For live valuation and market cap data, see market value of Ocumetics Technology Corp.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$-3.94 Million ≈ $-2.85 Million |
-103.69% |
| 2024-12-31 | CA$-1.94 Million ≈ $-1.40 Million |
-2225.30% |
| 2023-12-31 | CA$91.10K ≈ $65.90K |
-89.12% |
| 2022-12-31 | CA$837.40K ≈ $605.77K |
+409.58% |
| 2021-12-31 | CA$-270.50K ≈ $-195.68K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ocumetics Technology Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1574600100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$13.63 Million | % |
| Total Equity | CA$-3.94 Million | 100.00% |
Ocumetics Technology Corp Competitors by Market Cap
The table below lists competitors of Ocumetics Technology Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The LEADCORP Inc
KQ:012700
|
$49.87 Million |
|
Tanami Gold NL
AU:TAM
|
$49.89 Million |
|
Kanpur Plastipack Limited
NSE:KANPRPLA
|
$49.89 Million |
|
Springwater Special Situations Corp
NASDAQ:SWSS
|
$49.90 Million |
|
Sprint Bioscience AB
ST:SPRINT
|
$49.85 Million |
|
JUNGDAWN Co. Ltd
KQ:208140
|
$49.84 Million |
|
Tobii AB
ST:TOBII
|
$49.79 Million |
|
Synergetic Auto Performance Public Company Limited
BK:ASAP
|
$49.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ocumetics Technology Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,936,231 to -3,943,959, a change of -2,007,728.
- Net loss of 5,373,327 reduced equity.
- New share issuances of 2,148,191 increased equity.
- Other factors increased equity by 1,217,408.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-5.37 Million | -136.24% |
| Share Issuances | CA$2.15 Million | +54.47% |
| Other Changes | CA$1.22 Million | +30.87% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares Ocumetics Technology Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | CA$0.00 | CA$0.53 | x |
| 2022-12-31 | CA$0.01 | CA$0.53 | x |
| 2023-12-31 | CA$0.00 | CA$0.53 | x |
| 2024-12-31 | CA$-0.02 | CA$0.53 | x |
| 2025-12-31 | CA$-0.03 | CA$0.53 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ocumetics Technology Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-852.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | CA$-571.14K |
| 2022 | -265.10% | 0.00% | 0.00x | 1.64x | CA$-2.30 Million |
| 2023 | -3999.43% | 0.00% | 0.00x | 11.38x | CA$-3.65 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | CA$-2.83 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | CA$-4.98 Million |
Industry Comparison
This section compares Ocumetics Technology Corp's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,376,560,502
- Average return on equity (ROE) among peers: -13.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ocumetics Technology Corp (OTC) | CA$-5.09 Million | 0.00% | N/A | $49.86 Million |
| Bausch + Lomb Corp (BLCO) | $7.10 Billion | 0.21% | 0.57x | $5.39 Billion |
| Covalon Technologies Ltd. (COV) | $8.27 Million | -26.68% | 0.06x | $45.55 Million |
| ZEN Graphene Solutions Ltd (ZEN) | $20.42 Million | -14.77% | 0.01x | $44.91 Million |
About Ocumetics Technology Corp
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The comp… Read more